IRBESARTAN/HYDROCHLOROTHIAZIDE MYLAN PHARMA
As listed in the register: IRBESARTAN/HYDROCHLOROTHIAZIDE MYLAN PHARMA 300 mg/12,5 mg, comprimé pelliculé
12,5 mg + 300 mg · comprimé pelliculé
- Prescription only
- Active substance
- Hydrochlorothiazide + Irbésartan
- Made by
- MYLAN SAS
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | MYLAN SAS |
|---|---|
| Active substance | Hydrochlorothiazide + Irbésartan |
| Strength | 12,5 mg + 300 mg |
| Form | comprimé pelliculé |
| Route | orale |
| Dispensing (as stated by the register) | liste I |
| Marketed | No — authorised but not currently marketed, according to the register |
| Authorisation procedure | Procédure décentralisée |
| Name in the register | IRBESARTAN/HYDROCHLOROTHIAZIDE MYLAN PHARMA 300 mg/12,5 mg, comprimé pelliculé |
| Packs | plaquette(s) PVC polyéthylène PVDC aluminium de 30 comprimé(s) |
| CIS | 61956276 |
| CIP13 | 3400921782745 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).
Other strengths and forms
2 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- comprimé pelliculé2 products
- 12,5 mg + 300 mg
- 12,5 mg + 150 mg
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.